“Biopharmaceutical Third Party Logistics (3PL) Market Worth $87.62 Billion in 2019”, says Visiongain report

19 December 2019
Pharma

Visiongain’s new report the Biopharmaceutical Third Party Logistics (3PL) Market Report 2019-2029 : Forecasts by Supply Chain (Cold Chain, Non-Cold Chain), by Service Service Type (Transportation {Air Freight , Sea Freight , Overland Transportation}, Warehousing and Storage, Others), plus analysis of leading companies indicates that the global Biopharmaceutical Third Party Logistics (3PL) market will attain $137 billion revenue by 2029.

Global Biopharmaceutical Third Party Logistics market is expected to grow on account of increasing sales of biopharmaceutical and growing demand for safe delivery services for temperature-sensitive biologics. The market is expected to grow at a healthy CAGR of 4.6% over the projected period. In addition, increased demand for safe storage and transport of temperature-sensitive biopharmaceutical products are anticipated to reinforce the market concentration of biopharmaceutical 3PL over the projected period.

Over the past few years, demand for transportation outsourcing services has risen considerably. Outsourcing transportation services have led to reduced significant overheads of giant pharmaceutical companies. In addition, large biopharmaceutical businesses either sign an agreement or outsource services to 3PL service suppliers to decrease general operating costs, resulting in reduced pharmaceutical product prices. This has elevated the demand for biopharmaceutical 3PL services among giant biopharmaceutical companies.

In 2019, the Asia Pacific Biopharmaceutical Third Party Logistics (3PL) market accounted for more than 30% of overall market share. Strong economic growth followed by increasing sales of biopharmaceutical products in India, Japan, China, and Singapore is expected to increase Biopharmaceutical Third Party Logistics (3PL) market penetration over the forecast period. Asia Pacific market is growing on account of the growing aging population, the rising number of diseases is demanding for biologics and pharmaceuticals and high presence of CRO’s in the region.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever